Bank of Montreal’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-134
| Closed | -$1.54K | – | 4311 |
|
|
2023
Q4 | $1.54K | Buy |
134
+37
| +38% | +$446 | ﹤0.01% | 3903 |
|
|
2023
Q3 | $2.12K | Hold |
97
| – | – | ﹤0.01% | 3710 |
|
|
2023
Q2 | $7.75K | Hold |
97
| – | – | ﹤0.01% | 3821 |
|
|
2023
Q1 | $9.62K | Buy |
+97
| New | +$9.24K | ﹤0.01% | 3623 |
|
|
2022
Q4 | – | Sell |
-1,571
| Closed | -$481 | – | 4271 |
|
|
2022
Q3 | $481 | Buy |
1,571
+352
| +29% | +$102K | ﹤0.01% | 2607 |
|
|
2022
Q2 | $231 | Buy |
+1,219
| New | +$116K | ﹤0.01% | 3184 |
|
|
2021
Q2 | – | Sell |
-53
| Closed | -$27K | – | 4834 |
|
|
2021
Q1 | $27K | Sell |
53
-369
| -87% | -$230K | ﹤0.01% | 3946 |
|
|
2020
Q4 | $195K | Buy |
422
+155
| +58% | +$61.6K | ﹤0.01% | 3224 |
|
|
2020
Q3 | $105K | Sell |
267
-48
| -15% | -$21.2K | ﹤0.01% | 3048 |
|
|
2020
Q2 | $154K | Buy |
315
+86
| +38% | +$38.3K | ﹤0.01% | 2866 |
|
|
2020
Q1 | $82K | Sell |
229
-373
| -62% | -$193K | ﹤0.01% | 2680 |
|
|
2019
Q4 | $426K | Buy |
602
+230
| +62% | +$158K | ﹤0.01% | 2765 |
|
|
2019
Q3 | $238K | Sell |
372
-4
| -1% | -$3.17K | ﹤0.01% | 2807 |
|
|
2019
Q2 | $329K | Sell |
376
-248
| -40% | -$171K | ﹤0.01% | 2665 |
|
|
2019
Q1 | $360K | Sell |
624
-539
| -46% | -$225K | ﹤0.01% | 2438 |
|
|
2018
Q4 | $326K | Buy |
1,163
+572
| +97% | +$226K | ﹤0.01% | 2355 |
|
|
2018
Q3 | $284K | Buy |
591
+166
| +39% | +$71.2K | ﹤0.01% | 2576 |
|
|
2018
Q2 | $193K | Sell |
425
-54
| -11% | -$34.2K | ﹤0.01% | 2779 |
|
|
2018
Q1 | $282K | Sell |
479
-618
| -56% | -$385K | ﹤0.01% | 2469 |
|
|
2017
Q4 | $681K | Buy |
1,097
+46
| +4% | +$33K | ﹤0.01% | 2139 |
|
|
2017
Q3 | $967K | Sell |
1,051
-261
| -20% | -$232K | ﹤0.01% | 1988 |
|
|
2017
Q2 | $1.22M | Sell |
1,312
-115
| -8% | -$113K | ﹤0.01% | 1894 |
|
|
2017
Q1 | $1.36M | Buy |
1,427
+604
| +73% | +$562K | ﹤0.01% | 1739 |
|
|
2016
Q4 | $800K | Sell |
823
-109
| -12% | -$98.2K | ﹤0.01% | 1970 |
|
|
2016
Q3 | $787K | Buy |
932
+25
| +3% | +$20.1K | ﹤0.01% | 1917 |
|
|
2016
Q2 | $747K | Sell |
907
-4
| -0.4% | -$4.36K | ﹤0.01% | 1964 |
|
|
2016
Q1 | $1.01M | Buy |
911
+833
| +1,068% | +$853K | ﹤0.01% | 1744 |
|
|
2015
Q4 | $97K | Hold |
78
| – | – | ﹤0.01% | 2781 |
|
|
2015
Q3 | $105K | Buy |
78
+38
| +95% | +$62.7K | ﹤0.01% | 2595 |
|
|
2015
Q2 | $73K | Buy |
40
+1
| +3% | +$1.55K | ﹤0.01% | 2866 |
|
|
2015
Q1 | $63K | Buy |
+39
| New | +$57.8K | ﹤0.01% | 2837 |
|
|
2014
Q3 | – | Sell |
-13
| Closed | -$8K | – | 4385 |
|
|
2014
Q2 | $8K | Buy |
+13
| New | +$7.24K | ﹤0.01% | 3974 |
|
Other funds holding TCRT
MP
CB
ACM
Bank of Montreal's TCRT Position: Q1 2024 in Review
Bank of Montreal sold out of Alaunos Therapeutics (TCRT) in Q1 2024, closing a stake of 134 shares — an estimated $1.54K sold.
Bank of Montreal first reported a position in TCRT in Q2 2014 and held it in 32 quarters. The position peaked at $1.36M in Q1 2017. 45 funds tracked by Wall St. Rank hold TCRT as of Q1 2024.
- Bank of Montreal reported no remaining Alaunos Therapeutics position as of Q1 2024 after selling out during the quarter.
- Bank of Montreal sold 134 Alaunos Therapeutics shares in Q1 2024, an estimated $1.54K.
- Bank of Montreal first reported a position in Alaunos Therapeutics in Q2 2014 and held it in 32 quarters.
- Bank of Montreal's Alaunos Therapeutics position peaked at $1.36M in Q1 2017.
- 45 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q1 2024.
Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.